Orexigen Therapeutics, Inc.

CIK 1382911 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Orexigen Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jun 4, 2019SC 13D/A0001567619-19-012686
Jun 4, 201940001567619-19-012688
May 31, 201915-12B0001193125-19-162638
May 23, 20198-K0001193125-19-155290
May 3, 20198-K0001193125-19-135487
Apr 26, 2019CT ORDER9999999997-19-003511
Apr 2, 20198-K0001193125-19-095688
Mar 4, 20198-K0001193125-19-062410
Feb 14, 2019SC 13G/A0001537055-19-000004
Feb 14, 2019SC 13G/A0000921895-19-000488
Feb 12, 2019SC 13G/A0001213900-19-002219
Feb 12, 2019SC 13G/A0001213900-19-002211
Feb 11, 2019SC 13G/A0000905148-19-000275
Feb 5, 20198-K0001193125-19-028282
Dec 14, 20188-K0001193125-18-349919
Dec 4, 20188-K0001193125-18-342345
Oct 31, 2018SC 13D/A0001567619-18-004858
Oct 31, 20188-K0001193125-18-313990
Oct 31, 201840001567619-18-004867
Oct 26, 201840001567619-18-004622
Oct 26, 2018SC 13D/A0001567619-18-004621
Oct 19, 2018CT ORDER9999999997-18-008690
Oct 1, 20188-K0001193125-18-289569
Sep 5, 20188-K0001193125-18-266408
Jul 31, 20188-K0001193125-18-233370